Field notes, methodology and briefings on synthetic research, AI personas and decision intelligence.
How AI-powered synthetic personas and Decision Intelligence are reshaping pharma and life sciences market research — and what separates a usable platform from a demo.
A 2026 buyer's guide to the top synthetic research platforms for pharma and healthcare. Compare Acumen, ZoomRx, Within3, Sermo, Evidenza, and more on capabilities, pricing, and methodology.
A 2026 buyer's guide to the top HCP insights platforms for pharma. Compare Acumen, Sermo, Within3, ZoomRx, M3, and more on panel access, methodology, and pricing.
A 2026 buyer's guide to the top patient insights platforms for pharma. Compare Acumen, Inspire, PatientsLikeMe, ZoomRx, Health Union, and more on community access and methodology.
A 2026 buyer's guide to the top payer research and market access platforms for pharma. Compare Acumen, Avalere, Trinity, ClearView, IQVIA Market Access, and more.
A 2026 buyer's guide to the top pharma launch readiness platforms. Compare Acumen, Within3, ZoomRx, Veeva, IQVIA Launch Excellence, Trinity, and more on capabilities and methodology.
A 2026 buyer's guide to the top AI market research platforms for enterprise teams. Compare Acumen, Evidenza, Synthetic Users, ZoomRx, Yabble, and more on capabilities and methodology.
A 2026 buyer's guide to decision intelligence platforms for healthcare and pharma. Compare Acumen, Pyramid, Aera, ClosedLoop, Komodo, ZoomRx, Within3, and more across sub-categories.
Why the bigger problem in enterprise decision-making isn't bad research — it's the 80% of decisions that get made without any research at all.
An honest map of where AI personas extend traditional research, and where they shouldn't be allowed near the decision.
Why per-project fidelity beats published accuracy claims, and what a real calibration appendix looks like.
Why the next layer of enterprise customer intelligence is an operating system, not another dashboard.